https://orcid.org/0000-0002-7056-0885
Figures & data
Figure 1 Asthma Control Questionnaire-7 items.
Table 1 Baseline Characteristics
Table 2 Asthma Symptoms and Pulmonary Function at Inclusion (V1)
Table 3 Maintenance Medication/Active Substances Classes Used for Asthma Control Prior to Study Inclusion
Table 4 Pulmonary Function and ACQ-7
Figure 2 ACQ-7 score evolution.
Table 5 Asthma Symptoms Evolution During the Observational Study
Table 6 ACQ-7 Score and Asthma Symptoms for Patients Treated with Non-Extrafine BUD/F Prior V1, Followed by Extrafine BDP/FF 100/6 μg pMDI
Table 7 ACQ-7 Score and Asthma Symptoms for Patients Treated with FLU/SAL Prior V1, Followed by Extrafine BDP/FF 100/6 μg pMDI
Table 8 ACQ-7 Score and Asthma Symptoms for Patients Treated with Non-Extra Fine ICS-LABA Prior V1, Followed by Extrafine BDP/FF100/6 μg pMDI
Table 9 ACQ-7 for Different Extrafine BDP/FF 100/6 μg pMDI Treatment Regimens
Table 10 ACQ-7 Score and Treatment Adherence
Table 11 ACQ-7 Score Evolution
Table 12 Asthma Symptomatology Worsening Chronology
Figure 3 The average number of puffs of reliever medication used every day.
